Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Utah Signs SB 29 Drug Disposal Program Into Law, A Huge Step Forward for NarcX


“If prescription drugs that are no longer needed for those patients they were prescribed for are immediately destroyed onsite and not stockpiled, the diversion of these pills can be eliminated and lives throughout Utah, as well as the United States, can be saved.”

On April 1st, Governor Gary Herbert signed SB 29, “Drug Disposal Program,” into law. This legislation tasks the Utah Attorney General’s office with establishing a program for the secure, and environmentally friendly onsite disposal of lawfully possessed controlled substances.

In the midst of the opioid epidemic, every effort must be made to prevent unused opioids from being abused. This bill will lead to the destruction of millions of unused pills and pharmaceuticals that otherwise would be susceptible to being stockpiled and sold illegally.

NarcX stands ready to help in the fight against opioid abuse as the only independently-validated method of onsite destruction in the United States meeting DEA’s standard of non-retrievable. Former DEA Agent David Schiller said: “If prescription drugs that are no longer needed for those patients they were prescribed for are immediately destroyed onsite and not stockpiled, the diversion of these pills can be eliminated and lives throughout Utah, as well as the United States, can be saved.”

We congratulate the bill sponsors, Senator Daniel Thatcher and Representative Eric Hutchings, as well as the entire Utah State Legislature for demonstrating leadership in a time of crisis. In partnership with the State of Utah through the drug disposal program, NarcX will work to ensure that every hospital, pharmacy, hospice, senior living center, law enforcement agency, and home can safely and securely destroy all leftover opioids, preventing them from falling into the wrong hands.

NarcX is the leader in on-site medication disposal. Its patent-pending and environmentally safe product, NarcX, is the only liquid solution and on-site disposal option that is compliant with DEA policy and the Code of Federal Regulations. The proprietary blend of ingredients in NarcX immediately dissolves tablets, capsules and liquids, fully neutralizing compounds in under two hours as validated by an independent DEA-registered laboratory. Headquartered in Vineyard, Utah.

NarcX was founded with a mission to combat the diversion of narcotics, amphetamines, opiates and other frequently-abused controlled substances and to provide a convenient and affordable disposal option for unused, unwanted or expired medications. Through education and outreach, NarcX supports organizations in becoming compliant for medication disposal and destruction.

Related Links

http://www.NarcX.com

Share article on social media or email:

World Gastroenterology Organisation Announces World Digestive Health Day 2020 Gut Microbiome: A Global Perspective


News Image

By increasing awareness worldwide of the role that the gut microbiome may have in diagnosis, and how it can be modulated to treat disease and allay symptoms, we can affect overall human health and, in particular, among low- and middle-income countries.

The human gut microbiome contains tens of trillions of microorganisms and over 1,000 known species of bacteria, which have many important functions within the human body. Not surprisingly, there has been considerable interest and even more speculation on the role that gut microorganisms might play in health and disease. Gastroenterologists are frequently called upon to interpret, on behalf of their patients, the latest findings from basic and clinical research. To help sift through and assess the vast, complex, at times confusing, and ever-increasing body of literature and provide some guidance to the practicing clinician and their patients, the World Gastroenterology Organisation selected the Gut Microbiome as the focus of the 15th Annual 2020 World Digestive Health Day (WDHD), celebrated all year long, but highlighted on May 29th.

World Digestive Health Day focuses yearly upon a particular digestive disease or disorder to increase public awareness of the prevention, prevalence, diagnosis, management, and treatment of the disease or disorder worldwide. By increasing awareness worldwide of the role that the gut microbiome may have in diagnosis, and how it can be modulated to treat disease and allay symptoms, we can affect overall human health and, in particular, among low- and middle-income countries.

The WGO global network of member societies, partners, and sponsors is ideally positioned to raise awareness of the role the gut microbiome in human health. WGO invites those who are interested in joining the World Digestive Health Day 2020 initiative to visit http://www.worldgastroenterology.org/wgo-foundation/wdhd/wdhd-2020, or Facebook, Twitter, and Instagram @WorldGastroOrg.

ABOUT THE WORLD GASTROENTEROLOGY ORGANISATION

Formed in 1935 and incorporated in 1958, The World Gastroenterology Organisation (WGO) is a federation of 115 member societies and 4 regional associations of gastroenterology representing more than 50,000 individual members worldwide, focusing on the improvement of standards in gastroenterology training and education on a global scale. WGO’s mission is to promote, to the general public and healthcare professional alike, an awareness of the worldwide prevalence and optimal care of gastrointestinal and liver disorders, and to improve care of these disorders, through the provision of high quality, accessible and independent education and training.

ABOUT WORLD DIGESTIVE HEALTH DAY

The first World Digestive Health Day (WDHD) was held on 29 May 2005. Ever since, the World Gastroenterology Organisation (WGO) annually celebrates World Digestive Health Day by initiating a yearlong, worldwide, public health campaign through its 115 WGO Member Societies which reach over 50,000 individuals worldwide, WGO Training Centers, Regional Affiliate Associations, and other WGO global partners. Each year focuses upon a particular digestive disease or disorder in order to increase general public awareness of prevention, prevalence, diagnosis, management, and treatment of the disease or disorder.

To learn more about World Digestive Health Day activities or to join the celebration, please visit http://www.worldgastroenterology.org/wgo-foundation/wdhd/wdhd-2020, or Facebook, Twitter, and Instagram @WorldGastroOrg.

Share article on social media or email:

Voices of September 11th Coronavirus Response Tip Sheets Available Now


VOICES Coronavirus Response Program

“Our compilation of lessons learned is based on VOICES’ 19 years of experience in providing long-term support services for thousands of victims’ families, survivors, and responders, as well as extensive research that VOICES has conducted following other mass tragedies.” – Mary Fetchet

VOICES Coronavirus Response Tip Sheets are available online and can be downloaded at http://www.voicesofseptember11.org and include advice on Talking to Children About COVID-19; Guidance for Individuals and Families; Understanding Common Reactions to Stressful Situations; Mental Health Considerations; and Mental Health and Medical Resources.

The spread of the coronavirus is the most serious global health threat the world has faced in our lifetime. VOICES is responding by expanding its programs to provide additional support services and access to other resources.

Beyond serious medical concerns, VOICES recognizes that during this stressful time, one’s mental health and wellness could also be in jeopardy, and monitoring the signs and symptoms is critical. People may experience stress, fear, grief, depression and anxiety. Simple steps taken today can make a difference in one’s ability to cope with future coronavirus-related challenges.

“When it comes to maintaining positive mental health and wellness during the current health crisis, there are lessons to be learned by the response to the events of September 11, 2001, another tragedy that had international implications. Back then, families from over 90 countries lost a loved one. Now, the outbreak of the coronavirus has impacted the entire world,” said Mary Fetchet, Founding Director.

“We recognize the importance of early interventions to mitigate what could be long-term mental health consequences of the current global health crisis.

“Our compilation of lessons learned is based on VOICES’ 19 years of experience in providing long-term support services for thousands of victims’ families, survivors, and responders, as well as extensive research that VOICES has conducted following other mass tragedies,” said Fetchet.

About Voices of September 11th

Voices of September 11th (VOICES) is a 501 (c) (3) non-profit organization that was founded in 2001. The organization is led by Founding Director Mary Fetchet, a clinical social worker whose 24-year-old son Brad died in the terrorist attacks in New York City on September 11, 2001.

VOICES’ mission is to provide long-term support services, resources, and access to mental health care for 9/11 victims’ families, responders, and survivors, while leveraging our expertise to assist communities in their response and long-term recovery from acts of terrorism, mass violence, and other tragedies.

Through its partnership with the Centers for Disease Control (CDC) and the World Trade Center Health Program Centers of Excellence, VOICES assists survivors and responders in accessing treatment from the World Trade Center Health Program for mental health conditions, and life-threatening illnesses due their exposure to toxins in the aftermath of the attacks. VOICES 9/11 Living Memorial commemorates the 2,977 lives lost and documents stories of survivors.

VOICES Center for Resilience, dedicated in the memory of VOICES former Chairman Kurt Wolfgruber, leverages its expertise to assist communities impacted by acts of terrorism, mass violence and other tragedies by sharing lessons learned, conducting research and training. Working with a global network of public-private partnerships, the Center helps communities prepare for and respond to the short and long-term needs of communities impacted by mass trauma, in the United States and abroad.

For more information visit: http://www.voicesofseptember11.org

Share article on social media or email:

MD Revolution, Inc. launches turnkey Remote Patient Monitoring to all customers including COVID-19 screening and assessment


Kyle Williams, CEO | MD Revolution, Inc.

Kyle Williams, CEO | MD Revolution, Inc.

Remote Patient Monitoring is not just about devices and data. A successful RPM program must be paired with a patient engagement program to achieve sustainable results. RevUp provides this engagement, and delivers long-term health benefits to patients.

MD Revolution, Inc., announced today it has expanded its RevUp care management platform’s Remote Patient Monitoring service offering to include support for new devices and Medicare billing codes.

MD Revolution’s RevUp platform now offers an ideal combination of patient monitoring, assessment and management, incorporating full support for Annual Wellness Visits (AWV), Remote Patient Monitoring (RPM) and Chronic Care Management (CCM).

Effective immediately, the RevUp platform includes a COVID-19 screening and assessment tool, which has been rolled out to MD Revolution’s thousands of patients to help identify and slow the spread of the current pandemic. In addition to screening and assessment for COVID-19, MD Revolution’s care managers are providing patients with social support to combat isolation, as many patients are affected by orders to shelter-in-place.

MD Revolution’s Remote Patient Monitoring is available as a standalone service, or an upgrade path to current Chronic Care Management services through the RevUp platform.

“Remote Patient Monitoring is not just about devices and data,” according to Kyle Williams, CEO. “A successful RPM program must be paired with a patient engagement program to achieve sustainable results. RevUp provides this engagement, and delivers long-term health benefits to patients and fosters long-term relationships between medical practices and their patients.”

Remote Patient Monitoring

Remote monitoring of patients via connected devices has been an essential part of the MD Revolution Chronic Care Management service since its inception. Beginning in January 2020, and more recently expanded under the COVID-19 guidelines, Medicare has expanded access to RPM, which now affords MD Revolution’s clients the opportunity to offer RPM to their patients via their RevUp care management platforms. RPM codes provide reimbursement for a one-time patient education (CPT 99453), monthly device connection and transmission of data (CPT 99454) and monthly clinical monitoring and support (CPT 99457).

MD Revolution’s RPM service includes patient enrollment, seamless device provisioning and integration, education, monitoring and clinical support. Supported devices prompt patients to easily collect and securely transmit vital health information via the HIPAA-Compliant RevUp platform to skilled clinical professionals for monitoring. Patients can view their vitals in the web or mobile applications and communicate with their care team through secure app messaging or by phone. MD Revolution’s licensed teams work as an extension of the provider practice to manage patients, provide compliant documentation, escalate cases based on practice protocols and provide billing records. Integrated clients get the same automated billing claim creation as with Chronic Care Management services.

“MD Revolution has now been working with our patients for over 3 years. In these uncertain times, it is a comfort to know that we have the support of their team to work with our patients. We are now rapidly adding Remote Patient Monitoring services to our current contract. Without their help, we would have never been able to provide this benefit to our patients,” said Mary Edwards, Manager of Lake County Medical.

Importance of Patient Engagement

The RevUp care management platform works with a variety of integrated devices, including existing devices a client may already be using, in order to provide a fully connected patient engagement service.

“In this time when patient care means remote care, a comprehensive care management solution like RevUp is the key to supporting patients, managing capacity and growing a practice. Adding Remote Patient Monitoring to Chronic Care Management adds to the many ways we can support patients and providers,” summarized Williams.

More information about MD Revolution can be found on its website at mdrevolution.com.

About MD Revolution, Inc.

MD Revolution is an innovative Care Management company that uniquely combines technology, services, and analytics to produce scalable, high-touch care models that enrich the patient-provider experience and, more specifically, mitigate the challenges associated with meeting the requirements for Medicare’s Chronic Care Management (CCM) initiative, Behavioral Health Integration (BHI), population health programs, Annual Wellness Visits (AWV), as well as supporting Remote Patient Monitoring (RPM) and other digital health services. Solutions are available as turn-key solutions, software-as-a-service, and through reseller partners.

Press Contact:

Michael Moore

VP, Product Management

619/807-4007

michael.moore@mdrevolution.com

Share article on social media or email:

GoShip.com Helps Small Businesses and Individuals While Donating All Profits for Two Months to the CDC Foundation


GoShip.com to Donate All Profits for April and May to CDC Foundation

We’re fortunate to be classified as an essential business and to be in a position to help others.

GoShip.com, a digital shipping platform, is donating 100% of its profits from April and May to help the response to COVID-19. GoShip will be donating the profits to the CDC Foundation’s Emergency Response Fund, which provides support to rapidly emerging response needs related to COVID-19.

As a 24/7 digital shipping platform, GoShip is open all the time and requires no face-to-face contact—which is particularly relevant with social distancing and stay-at-home orders throughout the United States. Featuring a user-friendly interface, customers can conveniently place orders anytime and anywhere in just a few minutes while saving up to 30% over some of the better-known shipping options. GoShip has relationships with more than 50,000 freight carriers, providing shippers of all sizes the most cost-competitive shipping solutions.

GoShip.com Director of Product Ramesh Chalapalli said, “We’re fortunate to be classified as an essential business and to be in a position to help others. GoShip has continued to experience record-setting volumes throughout the COVID-19 pandemic, and we are pleased to be able to give back to the medical community.”

GoShip.com is a digital shipping platform that allows shippers of all sizes to electronically book full-truckload (FTL) and less-than-truckload (LTL) shipments at the press of a button, while enjoying highly competitive rates that are unavailable to most non-Fortune 500 shippers.

For more information, visit http://www.GoShip.com. To download the GoShip.com app, visit the Apple Store or Google Play on your Apple or Android device.

# # #

NOTE: If you’d like to schedule an interview with officials at GoShip.com, please contact Jeff Krakoff at 412-709-4199 or jeffk@krakoffcomm.com.

Share article on social media or email:

Encompass Group, LLC Quickly Responds to SONSIEL Urgent Call-to-Action on COVID-19


John Wood, CEO, Encompass Group, LLC

John Wood, CEO, Encompass Group, LLC

“Thank you to SONSIEL for finding creative ways to support our caregivers and all of the other heroes at the frontline of the COVID-19 battle.”

In the first of many consecutive efforts to respond to the national emergency to combat COVID-19, Encompass Group, LLC today announced a direct corporate donation through a national call-to-action program, SHARE, established and implemented by the Society of Nurse Scientists Innovators Entrepreneurs & Leaders (SONSIEL), in partnership with the GLO Good Foundation.

SONSIEL initiated SHARE—“Strengthen Healthcare Ability to Respond to Emergencies”—March 17, 2020 to instantly ignite community efforts to rapidly identify existing inventories of personal protective equipment (PPE) and move the urgently needed items to healthcare workers at high risk of infection. Through its network of professionals and volunteers, SONSIEL immediately called on non-hospital healthcare organizations and commercial businesses to help raise as much protective gear as possible, as quickly as possible, and to voluntarily move it into hot-spot areas. Within days, Encompass Group, LLC had committed to shipment of approximately 1,200 disposable jackets to assist frontline healthcare.

The Encompass Group, LLC SHARE donation was part of tens of thousands of pieces of protective gear conveyed from private and corporate donors to hospital healthcare staff in over a dozen hard-hit states. A March 20, 2020 ABC News NIGHTLINE episode featured SHARE program activity, with SONSIEL President & Co-Founder Rebecca C. Love and GLO Good Foundation Co-Founder Dr. Jonathan B. Levine. The NIGHTLINE story footage included jackets being packed and shipped out by Encompass Group, LLC.

Stated Rebecca C. Love, MSN, RN, SONSIEL President & Co-Founder, “Encompass Group, LLC was among the first organizations to say yes to our nationwide request for vitally needed PPE and we couldn’t be more grateful to the company and its hardworking people. Hundreds of frontline nurses, doctors, and technicians are working more safely today because of the swift decision to help by Encompass Group.”

Remarked John Wood, Encompass Group, LLC Chief Executive Officer, “We’re so happy we could help others by participating in the SHARE program. Credit goes to our staff, who set this up.”

Said Eric Howard, Encompass Group, LLC Vice President & General Manager, TECHStyles, “Encompass Group, LLC and our employees are fortunate to be in a position to be part of the solution during this difficult time. Thank you to SONSIEL for finding creative ways to support our caregivers and all of the other heroes at the frontline of the COVID-19 battle.”

Stay tuned for more news about Encompass Group, LLC efforts to respond to the national emergency to combat COVID-19. To learn more about Encompass Group, LLC, please visit https://www.encompassgroup.com. To support SONSIEL SHARE, visit https://bit.ly/GLOGoodxSONSIEL.

ABOUT ENCOMPASS GROUP, LLC

Encompass Group, LLC is one of the world’s leading manufacturers and marketers of reusable textiles, professional apparel, and disposable and single-use medical products. Encompass Group believes that every patient, resident, caregiver, and family member should feel safe and comfortable in today’s healthcare environments. Encompass Group enhances the healthcare experience by developing innovative products that are reliably delivered and cost-effective for all providers. Encompass Group serves the acute-care, long-term, and senior-care markets, retail healthcare and hospitality apparel markets, and government operations markets. For more information about Encompass Group, LLC, please visit https://www.encompassgroup.com.

Follow Encompass Group, LLC on LinkedIn at https://www.linkedin.com/company/encompass-group-llc/ (@encompass-group-llc); Twitter at https://twitter.com/EncompassGrpLLC (@EncompassGrpLLC); Facebook at https://www.facebook.com/EncompassGrpLLC (@EncompassGrpLLC); and YouTube at https://www.youtube.com/user/EncompassGroupLLC.

ABOUT SONSIEL

SONSIEL is a national and international platform of nurse scientists, innovators, and entrepreneurs, directly impacting health and the healthcare ecosystem through innovation and entrepreneurship; SONSIEL is a purpose-built society of nurses designed to create new opportunities and solutions across healthcare. Nurses are on the front lines, working with all healthcare team members to keep patients and the community safe. For more information about SONSIEL, please visit https://www.sonsiel.org/.

Follow SONSIEL on LinkedIn at https://www.linkedin.com/company/sonsiel/ (@SONSIEL); Twitter at https://twitter.com/SONSIEL2 (@SONSIEL2); Facebook at https://www.facebook.com/Sonsielnurse/ (@SONSIELnurse); Instagram at https://www.instagram.com/sonsielnurse/ (@SONSIELNURSE); and YouTube https://www.youtube.com/channel/UCpeapLA1QkY45l9NdOkxtQA/ (SONSIEL SONSIEL).

Share article on social media or email:



Commemorating The 30th Anniversary of Ryan White’s Death Due to HIV/AIDS Complications


The story of Ryan White's life, struggles and achievements are portrayed in the Power of Children exhibit at The Children's Museum of Indianapolis.

Ryan White and his mother, Jeanne White Ginder

It’s extremely important to pay attention to the medical evidence and listen to medical experts and let them be the ones who guide us—not rumor. We have a chance to do something right now to save lives and that’s to stay home.

In 1984, a teenager educated a frightened world about a deadly disease. Kokomo, Indiana native Ryan White was just 13-years-old when he contracted HIV/AIDS through a tainted blood product used to treat his hemophilia. There was widespread fear, ignorance and panic.

30 years later, the world is facing another horrible disease that is claiming lives, COVID-19. It is also causing fear and spreading panic around the world. Often, history teaches valuable lessons that can help with challenges faced today.

Following his diagnosis, White was banned from attending his high school classes. He wanted to live a normal life and attend school like all the other kids his age. But panic and fear gripped the nation. So, White’s family took the school to court to pursue Ryan’s right to attend classes. As his physical battle to fight the disease and the legal battle wore on, the White family moved to Cicero, Indiana where White was welcomed into Hamilton Heights High School. There, he made several new friends and earned his high school diploma. White’s influence spread to the entertainment industry. In fact, musician Elton John credits Ryan White with helping the singer turn his life around. Ryan died on April 8, 1990 from AIDS-related pneumonia at the young age of 18-years-old.

At the time, medical experts explained that HIV/AIDS was not spread through the air and that the disease was transmitted through tainted blood product, coming into direct contact with certain body fluids from a person with HIV such as blood, semen, and breast milk or from drug usage with tainted needles. Many people, however, did not understand or believe that. Ryan’s mother says things are not much different these days when it comes to disease. “There are a lot of similarities today with COVID-19 with how people are scared and everyone has an opinion on how you get the disease and how you don’t. It’s extremely important to pay attention to the medical evidence and listen to medical experts and let them be the ones who guide us—not rumor,” said Jeanne White Ginder. “We have a chance to do something right now to save lives and that’s to stay home.” White Ginder hopes people will work harder to be informed by the experts, make informed decisions as a result and show compassion. She went on to talk about how she still misses her son every day but is glad he made a huge difference in the world through the Ryan White Care Act, which provides a comprehensive system of HIV primary medical care, essential support services, and medications for people living with HIV to improve health outcomes and reduce HIV transmission among hard-to-reach populations. White Ginder has one regret, “We’ve not done our job by making the disease real to people. That was a big thing Ryan did. He made the disease real and it helped change lives.”

The Children’s Museum of Indianapolis proudly acquired all of the artifacts from Ryan’s teenage bedroom from his mother, Jeanne White Ginder. Under her watchful eye, the museum painstakingly recreated Ryan’s bedroom, which is part of the museum’s Power of Children permanent exhibit. She says some of Ryan’s happiest memories took place in that home, especially in his room filled with toy collections, posters and other memorabilia.

The world’s largest children’s museum is temporarily closed due to social gathering restrictions resulting from COVID-19; but, children and families can still learn more about Ryan White through a series of new blogs that can be found on The Children’s Museum website. Then when things return to normal, after the corona virus pandemic, Jeanne White Ginder plans to continue visiting Ryan’s room at The Children’s Museum of Indianapolis several times a year to share memories and stories about Ryan’s journey.

The courage and bravery of a young teenager fighting for his life and desire to be treated as a normal child is a strong message that stays with us today and can continue to help provide comfort and inspiration to people around the world facing difficult life circumstances.

About The Children’s Museum of Indianapolis

The Children’s Museum of Indianapolis is a nonprofit institution committed to creating extraordinary learning experiences across the arts, sciences, and humanities that have the power to transform the lives of children and families. For more information about The Children’s Museum, visit http://www.childrensmuseum.org, follow us on Twitter @TCMIndy, Instagram@childrensmuseum, YouTube.com/IndyTCM, and Facebook.

The Children’s Museum of Indianapolis is proud to partner with Riley Children’s at Indiana University Health, Old National Bank and Ice Miller LLP.

Share article on social media or email:

NeoTract Designates Dr. David Prall as UroLift® Center of Excellence


News Image

“We are proud to name Dr. David Prall as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that David Prall, D.O., Minnesota Urology in Woodbury, MN has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Prall has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. David Prall as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

InBios receives Emergency Use Authorization for its Smart Detect SARS-CoV-2 rRT-PCR Kit for detection of the virus causing COVID-19


InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Smart Detect SARS-CoV-2 rRT-PCR Kit. This real-time PCR test is intended for the qualitative detection of nucleic acid from SARS-CoV-2, the virus that causes COVID-19, in human nasopharyngeal, anterior nasal and mid-turbinate nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Clinical laboratories that are certified under Clinical Laboratory Improvement Amendments (CLIA) in the U.S. can immediately begin using this kit, which offers results in about 4 hours. This kit has been validated on the popular Applied Biosystems 7500 Fast Dx Real-Time PCR and the Biorad CFX96 Touch Real-Time PCR Detection System instruments.

Dr. Syamal Raychaudhuri, InBios’ chief scientific officer, said, “From the very early days, we (InBios) have been quick to respond to emerging global public health threats such as Zika, dengue and West Nile virus, but also cautious to only release products we are confident are of the highest performance and quality. The Smart Detect SARS-CoV-2 rRT-PCR Kit upholds our commitment to these high standards during this time when it is critical to meet the need for accurate testing for COVID-19.”

The Smart Detect SARS-CoV-2 rRT-PCR Kit is available to order immediately. It is the first of several diagnostic test kits being released by InBios to help diagnose COVID-19. In the coming weeks, serology kits for antibody detection will be available, which could help expand and contribute to a wider testing of the population that may be infectious for SARS-CoV-2 virus.

InBios is ramping up production of its COVID-19 diagnostic tests to meet the worldwide need. In 2018, InBios relocated to a larger, modern facility in South Lake Union area of Seattle, Washington, and has successfully increased production capacity and automation to support the ever-increasing demand for its high quality kits to support diagnostic testing during outbreaks of Zika, dengue, West Nile virus and now COVID-19.

While the Smart Detect SARS-CoV-2 rRT-PCR Kit has not been FDA cleared or approved, it has been authorized for use by the FDA under an EUA, which permits use of certain medical products that may be effective during a public health emergency, which was declared for COVID-19 on Jan. 31, 2020. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

For more information about InBios COVID-19 tests, visit: https://inbios.com/covid-19/

For more information on COVID-19, please visit http://www.cdc.gov or http://www.who.int

About InBios

InBios International Inc. specializes in the design, development and manufacture of diagnostic devices for emerging infectious diseases and biothreats. Founded in 1996 in Seattle, WA, our superior quality products are accurate, easy to use and cost effective. InBios offers an extensive catalog of life science reagents, along with a portfolio of more than 25 diagnostic products, including FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified.

Share article on social media or email:

Wash Hands Anywhere with Cambro’s Handwash Starter Station


The Handwash Starter Station is ideal for any essential business that is making the hygiene and safety of their employees a top priority.

Promote hygiene anywhere by making handwashing readily available with Cambro’s economic Handwash Starter Station. Lightweight and easy to move, the Handwash Starter Station can be set up anywhere inside or outside your operation. The Handwash Starter Station is ideal for any essential business that is making the hygiene and safety of their employees a top priority. Enabling employees to wash their hands closer to their workstations encourages more frequent handwashing and decreases the spread of bacteria.

During the COVID-19 pandemic, the CDC suggests cleaning hands “after you have been in a public place and touched an item or surface that may be frequently touched by other people, such as door handles, tables, gas pumps, shopping carts, or electronic cashier registers/screens, etc.” For many essential employees, frequently touching items and surfaces like the ones described is unavoidable. Cambro’s Handwashing Starter Station allows businesses to support the safety of their employees by providing increased sanitation in their facilities.

The Handwash Starter Station includes a 22 qt. Dispenser with Spigot and a 22 qt. Pail with Bail for collecting wastewater. Two “hand washing only” stickers clearly identify containers’ sanitation-only function. Both pails are designed with shatter and stain resistant plastic that withstands -40°F to 160°F (-40°C to 70°C) and molded-in handles and bails for easy lifting. We recommend using the Handwash Starter Station in conjunction with the Cambro KD Cart. Set up the Dispenser with Spigot on the top shelf of the KD Cart with the Pail with Bail directly underneath dispenser.

About Cambro Manufacturing

Cambro Manufacturing is a leading manufacturer and distributor of equipment and products to the foodservice industry worldwide. Brothers William and Argyle Campbell founded Cambro in 1951 with a small factory in Huntington Beach, Calif. More than 60 years later, Cambro is still a family-owned and privately held company committed to innovation, quality and value. More information on Cambro is available at http://www.cambro.com.

###

Share article on social media or email: